Guidance for Array BioPharma, Inc. (ARRY)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | $0.65 – $0.75 | $0.70 | $1.40B – 1.50B | $1.46B | = Maintained | Details |
| 2025 | $0.64 – $0.70 | $0.67 | $1.25B – 1.28B | $1.21B | = Maintained | Details |
| 2025 | N/A | N/A | $1.18B – 1.22B | $1.13B | = Maintained | Details |
| 2025 | $0.60 – $0.70 | $0.61 | $1.05B – 1.15B | $1.09B | = Maintained | Details |
| 2025 | N/A | N/A | $1.05B – 1.15B | $1.13B | = Maintained | Details |
| Q1 2025 | N/A | N/A | $260.00M – 270.00M | $219.50M | = Maintained | Details |
| 2024 | $0.60 – $0.65 | $0.65 | $900.00M – 920.00M | $945.00M | = Maintained | Details |
| 2024 | $0.64 – $0.74 | $1.08 | $900.00M – 1000.00M | $1300.00M |  Lowered |
Details |
| 2024 | N/A | N/A | $1.25M – 1.40M | $1.36M | = Maintained | Details |
| 2024 | $1.00 – $1.15 | $1.28 | $1.25B – 1.40B | $1.87B | = Maintained | Details |
| 2023 | $1.00 – $1.05 | $1.04 | $1.53B – 1.58B | $1.70B | = Maintained | Details |
| 2023 | $0.75 – $0.85 | $0.82 | $1800.00M – 1950.00M | $1891.00M | = Maintained | Details |
| 2022 | $0.32 – $0.37 | $0.30 | $1.50B – 1.60B | $1.48B | = Maintained | Details |
| 2022 | $0.25 – $0.35 | $0.31 | $1.30B – 1.50B | $1.40B | = Maintained | Details |
| 2022 | $0.25 – $0.35 | $0.56 | $1.30B – 1.50B | $1.49B | Lowered |
Details |
| 2022 | $0.55 – $0.74 | $0.66 | $1.45B – 1.75B | $1.39B | = Maintained | Details |
| 2021 | $0.82 – $0.92 | $0.87 | $1025.00M – 1125.00M | $989.00M | = Maintained | Details |
| 2020 | $0.15 – $0.25 | $0.43 | $850.00M – 940.00M | $991.00M | = Maintained | Details |
| Q4 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
